...
首页> 外文期刊>Ophthalmic Research: Journal for Research in Experimental and Clinical Ophthalmology >Corneal Collagen Crosslinking Combined with Phototherapeutic Keratectomy and Photorefractive Keratectomy for Corneal Ectasia after Laser in situ Keratomileusis
【24h】

Corneal Collagen Crosslinking Combined with Phototherapeutic Keratectomy and Photorefractive Keratectomy for Corneal Ectasia after Laser in situ Keratomileusis

机译:角膜胶原交联结合光照型角膜切除术和光反射术治疗激光原位角膜瘤后角膜枝肌肌瘤

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Purpose: The aim of this study was to analyze the effects of corneal crosslinking (CXL) combined with phototherapeutic keratectomy (PTK) and photorefractive keratectomy (PRK) in halting the progression and improving the visual function of corneal ectasia after laser in situ keratomileusis (LASIK). Methods: PTK-PRK-CXL was performed on 14 eyes of 14 patients who developed corneal ectasia after LASIK. The visual acuity, spherical refraction and cylinder, corneal topography indices, thinnest corneal thickness (TCT), and endothelial cell count were evaluated at baseline and at 1, 3, 6, and 12 months postoperatively. Results: The mean uncorrected visual acuity improved significantly from 0.64 +/- 0.36 logMAR preoperatively to 0.19 +/- 0.12 logMAR at 12 months of follow-up (p 0.001), while the mean best corrected visual acuity improved from 0.21 +/- 0.14 logMAR at baseline to 0.04 +/- 0.10 logMAR at 12 months postoperatively (p 0.001). A significant decrease was observed in Kmax and Kmean values from 52.51 +/- 6.74 and 43.55 +/- 3.37 D at baseline to 45.72 +/- 5.18 (p 0.001) and 40.60 +/- 3.05 D (p 0.001) at the 1-year follow-up. The mean TCT decreased significantly from 419.07 +/- 36.56 mu m before treatment to 320.93 +/- 39.78 mu m at 12 months of follow-up (p 0.001), and there was no significant endothelial cell loss (p 0.05) beyond 6 months after treatment. Conclusion: PTK-PRK-CXL is a promising procedure to halt the progression of post-LASIK keratectasia with significant visual quality improvement. (C) 2018 S. Karger AG, Basel
机译:目的:本研究的目的是分析角膜交联(CXL)与光治疗角膜切除术(PTK)和光折变角膜切除术(PRK)的影响在停止进展和改善激光的激光术后角膜外肌瘤的视觉功能(LASIK )。方法:PTK-PRK-CXL是在LASIK后14名患者的14名患者进行的。在基线和术后1,3,6和12个月内评估视力,球形折射和圆柱,角膜地形指数,最薄的角膜厚度(TCT)和内皮细胞计数。结果:平均未经矫正的视力从0.64 +/- 0.36 Logmar进行了改善到0.19 +/- 0.12 Logmar,在后续12个月(P <0.001),而平均最佳校正的视力从0.21 + / - 术后12个月的基线时为0.14 Logmar,在0.04 +/- 0.10 Logmar(P <0.001)。在基线的52.51 +/- 6.74和43.55 +/- 3.37d中以kmax和kmean值观察到显着的降低至45.72 +/- 5.18(p <0.001)和40.60 +/- 3.05d(p <0.001)在1年的随访。在治疗前419.07 +/-36.56μm,在320.93 +/- 39.78 mu m,在后续的12个月(p <0.001),并且没有明显的内皮细胞损失(P& 0.05 )治疗后超过6个月。结论:PTK-PRK-CXL是一个有望的程序,使LASIK Keratectasia的进展具有显着的视觉质量改进。 (c)2018年S. Karger AG,巴塞尔

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号